-
-
-
-
-
-
-
OSR Holdings advances biotech licensing deal worth up to $815 million
-
-
-
-
-
-
-
OSR Holdings Signs Definitive Agreement to Acquire Woori IO, a Pioneer in Noninvasive Glucose Monitoring with Potential to Transform Diabetes Care
-
-
-
-
-
-
-
OSR Holdings Provides Strategic Update on Woori IO Term Sheet and Share Exchange Structure
-
-
-
-
-
-
-
OSR Holdings plans $50 million security token offering for second half 2025
-
-
-
-
-
-
-
OSR Holdings' (OSRH) Vaximm AG Announces Results from Phase 2a Trial of VXM01 and Avelumab Combination Therapy in Glioblastoma
-
-
-
1,155,648 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

